| Oct 16 |
Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
|
| Oct 14 |
Mater Research initiates combined Covid-flu vaccine trial
|
| Oct 10 |
Novavax (NVAX) Advances While Market Declines: Some Information for Investors
|
| Oct 9 |
Novavax Inc (NVAX) Q2 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...
|
| Oct 9 |
Novavax gets EU authorization for updated COVID-19 vaccine
|
| Oct 9 |
Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EU
|
| Oct 7 |
Is Novavax, Inc. (NVAX) the Best High-Flying Stock to Buy?
|
| Oct 6 |
Novavax (NVAX): Analysts Are Bullish On This Under The Radar Stock Now
|
| Oct 3 |
Novavax (NVAX) Dips More Than Broader Market: What You Should Know
|
| Oct 3 |
Novavax: Lack Of Sustainable Revenue Growth Is A Problem
|
